Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Finasteride helps female-pattern hair loss.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

The injectable hydrogel effectively speeds up chronic wound healing.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Platelet-rich plasma shows promise for treating dry eye disease, but more standardized trials are needed.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.